Skip to main content
. 2020;20(3):429–436.

Figure 1.

Figure 1

Expression of miR-214 in patients with fragility fracture. (A) Expression of miR-214 in bone tissue of patients in control group and fragility fracture group. (B) Expression of miR-214 in blood of patients in control group and fragility fracture group. ***p<0.001: The difference is statistically significant.